Passage BIO PASG
NASDAQ PASG
$3.40 -0.11 (-3.13%)
At close: Oct 23, 2026 · 4:00 PM EDT

Passage BIO (PASG) Gains from Investment Securities (2020 - 2025)

Updated

Analysis

Passage BIO (PASG) Gains from Investment Securities (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Passage BIO 10.94 Mn -145.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -8,000.00
Dec 31, 2024 -24,000.00
Sep 30, 2024 99,000.00
Jun 30, 2024 2,000.00
Mar 31, 2024 -26,000.00
Dec 31, 2023 149,000.00
Sep 30, 2023 148,000.00
Jun 30, 2023 87,000.00
Mar 31, 2023 539,000.00
Dec 31, 2022 502,000.00
Sep 30, 2022 110,000.00
Jun 30, 2022 -244,000.00
Mar 31, 2022 -921,000.00
Dec 31, 2021 -446,000.00
Sep 30, 2021 14,000.00
Jun 30, 2021 36,000.00
Mar 31, 2021 -5,000.00
Dec 31, 2020 28,000.00
API Access

Passage BIO Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=PASG&period=max&api_key=YOUR_API_KEY